Among the DDR genes, the most frequent germline mutation in mCRPC is BRCA2, as evidenced in a multicenter study conducted by the Stand Up to Cancer–Prostate Cancer Foundation (SU2C–PCF) consortium [15,16]. The gene discussed is BRCA2; the disease is prostate carcinoma.